Worcester, MA, United States of America

David Ihle

USPTO Granted Patents = 6 

Average Co-Inventor Count = 7.9

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2013-2019

Loading Chart...
6 patents (USPTO):Explore Patents

Title: David Ihle: Innovator in Immunological and Oncological Treatments

Introduction

David Ihle is a prominent inventor based in Worcester, MA (US), known for his significant contributions to the field of pharmaceuticals. He holds a total of 6 patents, focusing on innovative compounds that have the potential to treat various immunological and oncological conditions.

Latest Patents

Among his latest patents, Ihle has developed indazolone compounds that serve as modulators of TNF signaling. The disclosures provide compounds of Formula (I), including pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers, and isomers. These compounds are designed to be effective in treating immunological and oncological conditions, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, David Ihle has worked with notable companies such as AbbVie Inc. and H. Lundbeck A/S. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Ihle has collaborated with esteemed colleagues, including Michael M. Friedman and Kelly Mullen. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

David Ihle's innovative work in developing compounds for treating serious health conditions highlights his role as a key inventor in the pharmaceutical field. His contributions continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…